Search
01/01/2022
Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins
Pou M.A., Orfila F., Pagonabarraga J., Ferrer-Moret S., Corominas H., Diaz-Torne C.. Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins. Revue Du Rhumatisme (edition Francaise). 2022; 89(6)DOI:10.1016/j.rhum.2022.09.019. PMID:. IF:(Q/D).
01/01/2022
Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert
Kulisevsky J.. Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert. REVISTA DE NEUROLOGIA. 2022; 75(s04)DOI:10.33588/rn.75s04.2022217. PMID:36342310. IF:1.200(Q4/10D).
01/01/2022
Efficacy and safety of high doses of safinamide in advanced Parkinson disease
Rodríguez-Jorge F., Beltrán-Corbellini Á., Chico-García J.L., Parra-Díaz P., Baena-Álvarez B., Pagonabarraga J., Pérez-Torre P., Pareés I., López-Sendón J.L., Martínez-Castrillo J.C., Alonso-Cánovas A.. Efficacy and safety of high doses of safinamide in advanced Parkinson disease. PARKINSONISM & RELATED DISORDERS. 2022; 97DOI:10.1016/j.parkreldis.2022.03.010. PMID:35344893. IF:(Q/D).
18/11/2025
Structured clinical diagnostic assessment reveals autism spectrum disorder in adults with functional neurological disorder
Gonzalez-Herrero, B, Coebergh, J, Pagonabarraga, J, Morgante, F, Deeley, Q, Edwards, MJ. Structured clinical diagnostic assessment reveals autism spectrum disorder in adults with functional neurological disorder. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-20508-6. PMID:41253885. IF:3.900(Q1/2D).